Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection

Table 2

The outcomes of RBTM and RATM treatment regimens.

	RBTM group ()	RATM group ()	value
Eradication rate
Intention-to-treat	92.1% (58/63)	90.2% (55/61)	0.71
Per-protocol	93.3% (56/60)	89.3% (50/56)	0.44
Compliance	96.8% (61/63)	96.7% (59/61)	0.97
Adverse events	22.2% (14/63)	42.6% (26/61)	0.02